trial · primary record
PF-06821497
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 609 |
| Primary completion | 2028-10-29 |
| Primary endpoint | Radiographic Progression Free Survival (rPFS) assessed by blinded independent central review (BICR) per RECIST v1.1 and Prostate Cancer Clinical Trials Working Group 3 (PCWG3) |
| Registry ID | NCT06551324 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:47.194Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06551324
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Pf-06821497 · compound